SomaGenics to present at the 7th non-coding RNA & RNAi Therapeutics conference, Boston, MA on September 14, 2016
Santa Cruz, CA, September 14, 2016 SomaGenics will present at the 7th non-coding RNA & RNAi Therapeutics conference by Global Technology Community on September 14 in Boston, MA. Dr. Johnston, CEO of SomaGenics, will present progress in SomaGenics’ Wound Healing program and briefly describe RealSeq®-AC, a novel method to prepare small RNA sequencing libraries with greatly reduced bias.
About SomaGenics, Inc. SomaGenics, Inc. is a privately held biotech company located in Santa Cruz, California. It specializes in developing innovative technologies that focus on RNA as therapeutic agents, targets and biomarkers as well as on RNA research and molecular diagnostic tools. The company’s technologies include the RealSeq® family for non-biased small RNA library construction for next-generation sequencing (NGS); miR-ID® and miR-Direct®, novel circularization-based RT-qPCR methods for small RNA detection; and ResQ™, a method for quantifying fragmented RNA. Somagenics’ therapeutic platform includes short synthetic hairpin RNA-based therapeutic candidates for wound healing and hepatitis delta virus (HDV). For more information visit somagenics.com